Press Releases

Press Releases

    Date Title View
    02/26/18
    Summary ToggleHorizon Pharma plc to Participate in the Cowen and Company 38th Annual Health Care Conference
    PDF Version
    02/22/18
    Summary ToggleHorizon Pharma plc Announces Release of the First RAREis™ Song in Partnership with Sing Me a Story Foundation and Global Genes
    PDF Version
    02/06/18
    Summary ToggleHorizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
    PDF Version
    01/30/18
    Summary ToggleHorizon Pharma plc Announces the Launch of “Cystinosis United” to Educate, Inspire and Connect the Cystinosis Community
    PDF Version
    01/29/18
    Summary ToggleHorizon Pharma plc to Release Fourth-Quarter and Full-Year 2017 Financial Results and Host Webcast on Feb. 28, 2018
    PDF Version
    01/08/18
    Summary ToggleHorizon Pharma plc Increases Peak Net Sales Guidance for Key Growth Drivers and Announces Rheumatology and Orphan Pipeline Developments
    PDF Version
    01/08/18
    Summary ToggleHorizon Pharma plc Announces Agreement to License Pre-Clinical Uricase Derivative (MEDI4945) from MedImmune
    PDF Version
    01/04/18
    Summary ToggleHorizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
    PDF Version
    12/27/17
    Summary ToggleHorizon Pharma plc Announces FDA Approval to Expand the Indication for PROCYSBI® (cysteamine bitartrate) Delayed-Release Capsules to Include Children One Year of Age and Older Living with Nephropathic Cystinosis
    PDF Version
    12/18/17
    Summary ToggleHorizon Pharma plc to Present at the 36th Annual J.P. Morgan Healthcare Conference
    PDF Version
    Displaying 31 - 40 of 406 results